Clinical aspects and risks of the phenol/croton oil

  • Authors:
    • Ioannis E. Liapakis
    • Georgios K. Ismailos
    • Angelos Michail
    • Georgios P. Tsakonis
    • Georgia Gloustianou
    • Ioannis Koliarakis
    • Apostolos D. Mandrekas
  • View Affiliations

  • Published online on: September 11, 2024     https://doi.org/10.3892/etm.2024.12711
  • Article Number: 422
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Phenol/croton oil is a unique chemical formulation promoting deep skin resurfacing and cellular renovation. Even though it has been used for decades in plastic surgery, the clinicopathological features, as well as the risks related to phenol/croton oil clinical application have not been thoroughly studied. The aim of the present study was to assess the effectiveness of the phenol/croton oil peel, the pathological characteristics from 1 patient at least and the emerging potential risks. A total of 64 patients were treated with phenol/croton oil peel between 2014 and 2023; in total, 21 of them underwent resurfacing at their oral area (upper/lower lips), 15 underwent resurfacing at their lower eyelid wrinkles, 22 patients underwent full face resurfacing, 2 patients were treated for their acne scars and additionally 4 patients were treated for multiple body seborrheic keratosis. The wrinkles, as well as the acne scars were markedly improved in all patients, the seborrheic keratosis was eliminated, while adverse events and undesired clinical manifestations related to peel intervention were mild and reversible for all patients. The application of phenol/croton oil constitutes an immensely powerful tool for deep chemical peeling and facial skin rejuvenation; nevertheless, it should be used cautiously due to its potential complications.
View Figures
View References

Related Articles

Journal Cover

November-2024
Volume 28 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liapakis IE, Ismailos GK, Michail A, Tsakonis GP, Gloustianou G, Koliarakis I and Mandrekas AD: Clinical aspects and risks of the phenol/croton oil. Exp Ther Med 28: 422, 2024.
APA
Liapakis, I.E., Ismailos, G.K., Michail, A., Tsakonis, G.P., Gloustianou, G., Koliarakis, I., & Mandrekas, A.D. (2024). Clinical aspects and risks of the phenol/croton oil. Experimental and Therapeutic Medicine, 28, 422. https://doi.org/10.3892/etm.2024.12711
MLA
Liapakis, I. E., Ismailos, G. K., Michail, A., Tsakonis, G. P., Gloustianou, G., Koliarakis, I., Mandrekas, A. D."Clinical aspects and risks of the phenol/croton oil". Experimental and Therapeutic Medicine 28.5 (2024): 422.
Chicago
Liapakis, I. E., Ismailos, G. K., Michail, A., Tsakonis, G. P., Gloustianou, G., Koliarakis, I., Mandrekas, A. D."Clinical aspects and risks of the phenol/croton oil". Experimental and Therapeutic Medicine 28, no. 5 (2024): 422. https://doi.org/10.3892/etm.2024.12711